Karuna Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Karuna Therapeutics, Inc. has filed 460 SEC EDGAR filings since 29 Mar 2019

SEC filing history

Showing 1-25 of 460 matching filings.

Per page
25
Current page
1
15-12G File 001-38958

15-12G

Filing date
28 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
15 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-269927

S-8 POS

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-262946

S-8 POS

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-253501

S-8 POS

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-237360

S-8 POS

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-232521

S-8 POS

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-38958

25-NSE filing

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-272813

POSASR

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .